HARTLINE INVESTMENT CORP/ – Bristol-Myers Squibb Company Transaction History
HARTLINE INVESTMENT CORP/ portfolio value:
$0
portfolio value
HARTLINE INVESTMENT CORP/ quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -26.62K shares | -1.65M | $71.09 | 0 |
| Q2 2022 | share | Increase | +102.21% | 13.45K shares | 771K | $77 | 26.62K |
| Q1 2022 | share | Increase | +36.46% | 3.51K shares | 278K | $73.03 | 13.16K |
| Q4 2021 | share | Decrease | -25.23% | -3.25K shares | -161K | $62.52 | 9.64K |
| Q3 2021 | share | Decrease | -2.00% | -263 shares | -117K | $59.17 | 12.90K |
| Q2 2021 | share | Decrease | -14.13% | -2.16K shares | -88K | $65.79 | 13.16K |
| Q1 2021 | share | Decrease | -42.41% | -11.29K shares | -683K | $62.15 | 15.33K |
| Q4 2020 | share | Decrease | -22.70% | -7.81K shares | -425K | $60.6 | 26.62K |
| Q3 2020 | share | Decrease | -48.88% | -32.93K shares | -1.88M | $58 | 34.44K |
| Q2 2020 | share | Decrease | -12.13% | -9.29K shares | -312K | $56.14 | 67.37K |
| Q1 2020 | share | Decrease | -2.00% | -1.56K shares | -748K | $52.79 | 76.67K |
| Q4 2019 | share | Increase | 0.00% | 78.24K shares | 5.02M | $60.36 | 78.24K |